FDA's Inaction On Issuing Licensing Rules For Wholesalers and 3PLs Creating Confusion
Agency May Be Forced To Issue Rule Through Litigation, Says Attorney
Executive Summary
Highly anticipated proposed rulemaking from the FDA on licensing standards for wholesale distributors and third-party logistics providers has been repeatedly delayed, and the reasons for the delay are unclear. The rule is five years overdue under a DSCSA mandated timeline.
You may also be interested in...
US FDA’s Drug Distributor Licensing Plan Preempts Potentially Stricter State Rules
Proposed rule will pre-empt state licensure requirements for wholesale drug distributors two years after it becomes final and for third-party logistics providers after one. National licensure system expected to make it more difficult for bad actors to distribute illegitimate drug products, but in the meantime current patchwork of state licensure requirements will apply.
US FDA’s Drug Distributor Licensing Plan Preempts Potentially Stricter State Rules
National plan would close regulatory gaps in licensure of wholesalers and shipping companies, but also backs away from earlier idea to let states set stricter requirements.
US FDA Still “Actively” Drafting Proposed Licensing Rule For Wholesalers and 3PLs
Pharmaceutical manufacturers should have already begun serializing products and verifying saleable returns to comply with DSCSA, says FDA official who also asserted that licensing standards for wholesale distributors and third-party logistics providers will be forthcoming. This rule is already six years overdue under a DSCSA mandated timeline.